Items where authors include "Boyd, K."

Article

Cook, G., Ashcroft, A.J., Senior, E. et al. (17 more authors) (2024) Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology, 11 (11). e816-e829. ISSN 2352-3026

Cook, G., Ashcroft, A.J., Senior, E. et al. (17 more authors) (2024) Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial. The Lancet Haematology, 11 (11). e816-e829. ISSN 2352-3026

Turner, N. orcid.org/0000-0002-0870-8324, Wahid, A., Oliver, P. et al. (8 more authors) (2023) Role and response of primary healthcare services in community end-of-life care during COVID-19: Qualitative study and recommendations for primary palliative care delivery. Palliative Medicine, 37 (2). pp. 235-243. ISSN 0269-2163

Turner, N., Wahid, A., Oliver, P. et al. (8 more authors) (2023) Role and response of primary healthcare services in community end-of-life care during COVID-19: qualitative study and recommendations for primary palliative care delivery. Palliative Medicine, 37 (2). pp. 235-243. ISSN 0269-2163

Kendall, J. orcid.org/0000-0003-2884-4849, Hall, A., Roberts, S. et al. (5 more authors) (2022) MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. BMJ Open, 12 (10). e062504. ISSN 2044-6055

Mitchell, S., Harrison, M., Oliver, P. et al. (7 more authors) (2022) Service change and innovation in community end-of-life care during the COVID-19 pandemic: qualitative analysis of a nationwide primary care survey. Palliative Medicine, 36 (1). pp. 161-170. ISSN 0269-2163

Mitchell, S. orcid.org/0000-0002-1477-7860, Harrison, M. orcid.org/0000-0001-9874-921X, Oliver, P. et al. (7 more authors) (2022) Service change and innovation in community end-of-life care during the COVID-19 pandemic: Qualitative analysis of a nationwide primary care survey. Palliative Medicine, 36 (1). pp. 161-170. ISSN 0269-2163

Mitchell, S., Oliver, P., Gardiner, C. et al. (6 more authors) (2021) Community end-of-life care during COVID-19 : findings of a UK primary care survey. BJGP Open, 5 (4). BJGPO.2021.0095. ISSN 2398-3795

Murray, S.A., Mitchell, S. orcid.org/0000-0002-1477-7860, Boyd, K. et al. (1 more author) (2019) Palliative care : training the primary care workforce is more important than rebranding. British Medical Journal (BMJ), 2019 (365). l4119. ISSN 1759-2151

Proceedings Paper

Reed, M., Cairns, D.A. orcid.org/0000-0002-2338-0179, Pawlyn, C. et al. (13 more authors) (2023) The Impact of Epstein-Barr Virus Infection on Second Cancer Development in Newly Diagnosed Myeloma Patients Treated with Lenalidomide in the UK NCRI Myeloma XI Trial. In: Blood. 65th ASH Annual Meeting and Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 3366-3368.

Cook, G., Ashcroft, A.J., Senior, E.R. et al. (16 more authors) (2023) Ixazomib-based consolidation and maintenance prolongs progression-free survival after salvage autologous stem cell transplantation (sASCT): Results from interim analysis of UK-MRA myeloma XII (ACCoRD). In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 783.

Lawless, C., Boyd, K., Faivre-Finn, C. et al. (9 more authors) (2018) ADSCaN: a randomised phase ii study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). In: Lung Cancer. The 16th Annual British Thoracic Oncology Group Conference 2018, 24-26 Jan 2018, Dublin . Elsevier , S88-S89.